Santoro M - Search Results

1

The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC.

Rusciano MR, Salzano M, Monaco S, Sapio MR, Illario M, De Falco V, Santoro M, Campiglia P, Pastore L, Fenzi G, Rossi G, Vitale M. Rusciano MR, et al. Among authors: santoro m. Endocr Relat Cancer. 2010 Jan 29;17(1):113-23. doi: 10.1677/ERC-09-0214. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19903742

2

Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells.

Califano D, Monaco C, de Vita G, D'Alessio A, Dathan NA, Possenti R, Vecchio G, Fusco A, Santoro M, de Franciscis V. Califano D, et al. Among authors: santoro m. Oncogene. 1995 Jul 6;11(1):107-12. Oncogene. 1995. PMID: 7624117

3

Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line.

Carlomagno F, Salvatore D, Santoro M, de Franciscis V, Quadro L, Panariello L, Colantuoni V, Fusco A. Carlomagno F, et al. Among authors: santoro m. Biochem Biophys Res Commun. 1995 Feb 27;207(3):1022-8. doi: 10.1006/bbrc.1995.1287. Biochem Biophys Res Commun. 1995. PMID: 7864888

4

Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.

Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti MA. Bongarzone I, et al. Among authors: santoro m. Cancer Res. 1994 Jun 1;54(11):2979-85. Cancer Res. 1994. PMID: 8187085

5

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.

Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli ML, Paulin C, et al. Santoro M, et al. Br J Cancer. 1993 Sep;68(3):460-4. doi: 10.1038/bjc.1993.370. Br J Cancer. 1993. PMID: 8353035 Free PMC article.

6

The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line.

Santoro M, Melillo RM, Grieco M, Berlingieri MT, Vecchio G, Fusco A. Santoro M, et al. Cell Growth Differ. 1993 Feb;4(2):77-84. Cell Growth Differ. 1993. PMID: 8494786

7

The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.

Carlomagno F, Salvatore G, Cirafici AM, De Vita G, Melillo RM, de Franciscis V, Billaud M, Fusco A, Santoro M. Carlomagno F, et al. Among authors: santoro m. Cancer Res. 1997 Feb 1;57(3):391-5. Cancer Res. 1997. PMID: 9012462

8

Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors.

De Vita G, Zannini M, Cirafici AM, Melillo RM, Di Lauro R, Fusco A, Santoro M. De Vita G, et al. Among authors: santoro m. Cell Growth Differ. 1998 Jan;9(1):97-103. Cell Growth Differ. 1998. PMID: 9438393

9

Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.

Chiariello M, Visconti R, Carlomagno F, Melillo RM, Bucci C, de Franciscis V, Fox GM, Jing S, Coso OA, Gutkind JS, Fusco A, Santoro M. Chiariello M, et al. Among authors: santoro m. Oncogene. 1998 May 14;16(19):2435-45. doi: 10.1038/sj.onc.1201778. Oncogene. 1998. PMID: 9627110 Free article.

10

Molecular biology of the MEN2 gene.

Santoro M, Melillo RM, Carlomagno F, Visconti R, De Vita G, Salvatore G, Lupoli G, Fusco A, Vecchio G. Santoro M, et al. J Intern Med. 1998 Jun;243(6):505-8. doi: 10.1046/j.1365-2796.1998.00330.x. J Intern Med. 1998. PMID: 9681850 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,757 results

Search Page

Filters